title: What is the optimal venous thromboembolism prophylaxis for gynecological oncology patients with CNS metastases?
authors.affiliation: Department of Neurological Surgery, University of Wisconsin School of Medicine and Public Health, Madison WI, USA. c.baggott@neurosurgery.wisc.edu
authors.forename: Christopher D
authors.initials: CD
authors.lastname: Baggott
authors.forename: M Heather
authors.initials: MH
authors.lastname: Einstein
authors.forename: Amrendra
authors.initials: A
authors.lastname: Miranpuri
authors.forename: Stephen L
authors.initials: SL
authors.lastname: Rose
authors.forename: John S
authors.initials: JS
authors.lastname: Kuo
mesh_terms: D001932:Brain Neoplasms / Q000556:secondary*; D005260:Female; D005833:Genital Neoplasms, Female / Q000473:pathology*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D054556:Venous Thromboembolism / Q000517:prevention & control*
chemical_list: D006493:Heparin